Published in Pharma Law Weekly, July 26th, 2005
Thiopurine therapies are used to treat patients with childhood leukemia, autoimmune diseases and organ transplants. The Mayo researchers said their finding advances the field of pharmacogenomics, which tailors medicine to a patient's personal genetic makeup.
In Proceedings of the National Academy of Sciences, the researchers reported that...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.